Syndax Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SNDX for the last quarter is 12.50 M USD, and it's 257.14% higher compared to the previous quarter. The net income of Q3 24 is -84.13 M USD.